SEC Form 4 · accession 0001209191-15-036394
Kura Oncology, Inc. · KURA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Annette North
Officer — SVP, General Counsel
Period of report
Apr 23, 2015
Accepted (ET)
Apr 27, 2015 · 4:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001422143
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase common stockF1 | $6.32 | Apr 23, 2015 | A | 81,250 | A | — | Apr 22, 2025 | Common stock | 81,250 | 81,250 | D |
Explanation of responses
- F1This option vests as follows: one-fourth on January 12, 2016 and 1/48th each month thereafter for the remaining three years.